Univ. W-M, WI

Dr. Forsberg’s work has focused on the development of novel biotechnologies directed towards treating human diseases.  At Infigen, Inc. and subsequently Pharming Group, NV, his work was instrumental in the generation of genetically engineered animals targeted to produce human proteins and ‘humanized’ organs for treating conditions including hereditary angioedema, organ failure, organ rejection following transplant, and uncontrolled bleeding.  His is also contributing to the development of new a gene therapy approach to treat type I diabetes as a senior scientist in the Department of Surgery at the UW-Madison.  After graduating from Kalamazoo College, he earned a Ph.D. in pharmacology and physiology from the University of Chicago and did his postdoctoral work at the NIH.  He was subsequently appointed assistant professor of physiology at the University of Wisconsin-Madison where he elucidated several signal transduction pathways in the adrenal gland.  In his current position as the executive director of WiCell, Dr. Forsberg is working to build WiCell’s collaborative R&D efforts with universities, non-profit organizations and companies to promote the translation of basic stem cell research into new therapies and diagnostics for unmet medical needs.

Return to list of speakers